Abstract
AbstractThis chapter focuses on the role of imaging, in particular magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography (FDG-PET), for the evaluation of patients with cervical cancer (CC) and endometrial cancer (EC).
Publisher
Springer International Publishing